← Open Payments lookup

CHERYL LUMMIS: Open Payments

NPI 1962438762 · MEXICO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,037 in 64 payments from 17 companies in 2025. Trend: 2023 $872 · 2024 $1,140 · 2025 $1,037

Food & beverage: $1,037
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$213
AstraZeneca Pharmaceuticals LP4$140
Teva Pharmaceuticals USA, Inc.16$135
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$98
Lundbeck LLC5$96
ABBVIE INC.5$85
Otsuka America Pharmaceutical, Inc.3$72
Vanda Pharmaceuticals Inc.2$32
Corcept Therapeutics2$30
Viatris Specialty LLC1$24

Products named: INGREZZA, REXULTI, AIRSUPRA, CAPLYTA, AUSTEDO XR, VRAYLAR, UZEDY, FANAPT.

Industry payments across MO — which companies pay providers there.